Fixed-dose low-molecular-weight heparin, bemiparin, in the long-term treatment of venous thromboembolism in patients with transient risk factors in standard clinical practice: The FLEBUS study [7]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 11, 2006, Pages 2504-2508

  Lecumberri, Ramón ^a   Rosario, E ^b,d   Pacho, J ^c   Rocha, E ^a   Soler, G ^d   Santamaria A ^e   Rodriguez J ^f   Pia, G ^g   Pastor, J O ^h   Reuss, J M ⁱ   de Ramon E ^j   Diaz C ^j   Trujillo, A J ^k   Buisan, J M ^l   Soles, J ^m   Minguela, F ⁿ   Marin A ^o   Antigues, I ^p   Nieto, M M ^q   Otero, R ^r   Ramos, E H ^s   Vazquez F ^k   Dominguez I M ^t   Baloira, A ^u   Cardona, M ^v   Gonzalez A J ^w   Frutos de, J L ^x   Fernandez Paredes R ^x   Gallego, P ^y   Vidal Barraquer, F ^z   Gamboa, F ^aa   Todoli J A ^ab   Cervero A ^ac   Pineda, A ^ad   Llamas, P ^ae   Abad, C M ^af   Rodriguez P ^ag   Royo, J L ^ah   Lopez F ^x   Molina, F ^ai   more..

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d H Clínico Universitario   (Spain)

^e H Sant Pau   (Spain)

^f HOSPITAL PLATÓ   (Spain)

^g Universidad de La Coruña   (Spain)

^h H de Granollers   (Spain)

ⁱ RPPMM   (Spain)

^j H Carlos Haya   (Spain)

^k H Costa del Sol ^*  (Spain)

^l Lozano Blesa Hospital   (Spain)

^m Clínica Bofia   (Spain)

ⁿ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^o Centro de Salud Mental Infantil Molina de Segura   (Spain)

^p H Gral Universitario   (Spain)

^q Hospital Neurotraumatológico   (Spain)

^r HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^s H Clínico Universitario   (Spain)

^t H de Torrecárdenas   (Spain)

^u Hospital de Pontevedra   (Spain)

^v Hospital Creu Roja   (Spain)

^w San Agustin Hospital   (Spain)

^x HOSPITAL ARNAU DE VILANOVA   (Spain)

^y H Jerez de la Frontera   (Spain)

^z H del Mar   (Spain)

^aa HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^ab H La Fe   (Spain)

^ac H Gral Univ   (Spain)

^ad Centro de Salud Condes de Barcelona   (Spain)

^ae Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^af HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^ag Clinica San Miguel   (Spain)

^ah HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^ai Hosp Univ Ciudad de Jaén   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BEMIPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; BLEEDING; CAUSE OF DEATH; CHRONIC DRUG ADMINISTRATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LETTER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; SECONDARY PREVENTION; THROMBOCYTOPENIA; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INSTITUTIONAL PRACTICE; MALE; MIDDLE AGED; RISK FACTORS; THROMBOEMBOLISM; TIME FACTORS;

EID: 33750049003     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02171.x     Document Type: Letter

References (17)

1. Iorio A, Guercini F, Pini M. Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: Meta-analysis of the randomized comparisons with oral anticoagulants. J Thromb Haemost 2003; 1: 1906-13.
2. van der Heijden JF, Hutten BA, Buller HR, Prins MH. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev 2002; 1: CD002001.
3. Lecumberri R, Feliu, J, Rocha E. Nuevas estrategias en la prevención secundaria de la recurrencia de la tromboembolia venosa. Med Clin (Barc) 2005; 125: 748-55.
4. Meyer G, Marjanovic Z, Valcke J, Lorcerie B, Gruel Y, Solal-Celigny P, Le Maignan C, Extra JM, Cottu P, Farge D. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: A randomized controlled study. Arch Intern Med 2002; 162: 1729-35.
5. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M, for the Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous, Thromboembolism in Patients with Cancer (CLOT) Investigators. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-53.
6. Monreal M, Zacharski L, Jimenez JA, Roncales J, Vilaseca B. Fixed-dose low-molecular-weight heparin for secondary prevention of venous thromboembolism in patients with disseminated cancer: A prospective cohort study. J Thromb Haemost 2004; 2: 1311-5.
7. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 401S-28S.
8. Planes A. Review on bemiparin sodium - a new second generation low-molecular-weight heparin - and its applications in venous thromboembolism. Expert Opin Pharmacother 2003; 4: 1551-61.
9. Kakkar VV, Gebska M, Kadziola Z, Saba N, Carrasco P. Bemiparin Investigators. Low-molecular-weight heparin in the acute and long-term treatment of deep vein thrombosis. Thromb Haemost 2003; 89: 674-80.
10. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists. Chest 2004; 126: 204S-33S.
11. Hull RD, Delmore T, Carter C, Hish J, Genton E, Gent M, Turpie G, McLaughlin D. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med 1982; 306: 189-94.
12. Monreal M, Lafoz E, Olive A, del Rio L, Vedia C. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thromb Haemost 1994; 71: 7-11.
13. Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-5.
14. Pini M, Aiello S, Manotti C, Pattacini C, Quintavalla R, Poli T, Tagliaferri A, Dettori AG. Low-molecular-weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis. Thromb Haemost 1994; 72: 191-7.
15. Lopaciuk S, Bielska-Falda H, Noszczyk W, Bielawiec M, Witkiewicz W, Filipecki S, Michalak J, Ciesielski L, Mackiewicz Z, Czestochowska E, Zawilska K, Cencora A. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis. Thromb Haemost 1999; 81: 26-31.
16. Santamaria A, Juarez S, Reche A, Gomez-Outes A, Martinez-Gonzalez J, Fontcuberta J, ESFERA Investigators, Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: The ESFERA Study. Int J Clin Pract 2006; 60: 518-25.
17. Gomez-Outes A, Rocha E, Martinez Gonzalez J, Kakkar VV. Cost effectiveness of bemiparin versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis. Pharmacoeconomics 2006; 24: 81-92.